[Vascular diseases in CKD-MBD]

Atsushi Shioi1

  • 1Department of Vascular Medicine, Osaka City University Graduate School of Medicine, Japan.

Clinical Calcium
|May 28, 2016
PubMed

Insights

Vascular calcification, a key aspect of chronic kidney disease-mineral and bone disorder, drives cardiovascular death. Targeting medial calcification is crucial for developing new therapies to prevent heart disease in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Vascular calcification is integral to chronic kidney disease-mineral and bone disorder (CKD-MBD).
  • CKD-MBD involves vascular lesions like atherosclerosis and arteriosclerosis, contributing to cardiovascular disease (CVD).
  • Epidemiological data indicate myocardial disease, not atherothrombotic disease, is the primary cause of cardiovascular death in CKD.

Purpose of the Study:

  • To highlight the significance of medial calcification in CKD-MBD.
  • To underscore the link between medial calcification, arterial stiffness, and myocardial disease.
  • To emphasize the need for novel therapeutics targeting medial calcification.

Main Methods:

  • Review of epidemiological data on cardiovascular mortality in CKD.
  • Analysis of the pathophysiology of vascular calcification in CKD-MBD.
  • Examination of the relationship between arteriosclerosis, medial calcification, and myocardial disease.

Main Results:

  • Atherosclerotic intimal calcification and medial calcification contribute to CVD progression.
  • Arteriosclerosis, characterized by medial arterial layer thickening and calcification, increases arterial stiffness.
  • Medial calcification is a key contributor to the development of myocardial disease in CKD.

Conclusions:

  • Medial calcification is a critical factor in CKD-MBD and cardiovascular mortality.
  • Increased arterial stiffness due to medial calcification promotes myocardial disease.
  • Developing novel therapeutics for medial calcification is essential for managing cardiovascular risk in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
906
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.0K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
590
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
577
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
589